Y Combinator’s Graham: Build ‘stuff you’re genuinely interested in’

Taking advantage of the opportunities a college education affords and doing what you love are important in a successful startup journey, according to Paul Graham ’86, founder of Y Combinator.

University to mark Veterans Week with celebration, reflection

The Cornell Veterans Celebration on Nov. 9 kicks off a week of events honoring the land-grant university's military community and history of service.

Is faith feminine? Why US churches have men in pulpits, women in pews

In a new book, sociologist Landon Schnabel debunks assumptions that women are inherently more religious and explains why many Americans are disengaging from religious institutions while maintaining personal spirituality.

Hundreds of students attend new startup career fair

The expo brought together companies in fields from robotics to defense to health tech to food.

Around Cornell

Professors defend their disciplines in apocalypse debate

Five professors from across campus will advocate that their discipline is the most important to save in the annual Apocalypse Debate, sponsored by Logos, the undergraduate philosophy journal and club.

Around Cornell

All-natural materials promote regenerative architecture

Straw, mycelium, hemp and dirt are building blocks in Marta Wisniewska's research and teaching focused on designing healthier spaces that mitigate the construction industry’s environmental impact.

New initiative will explore AI’s role in society, humanities

With AI transforming how societies function, a new program in the College of Arts and Sciences aims to meet the urgent need to understand AI’s implications for culture, governance, ethics, communication, creativity, labor and social organization.

$750K Wake Forest grant advances cultural humility across Cornell

The three-year grant will allow Cornell to explore how community-engaged learning can more intentionally cultivate cultural humility as a foundation for ethical practice and civic participation.

Weill Cornell receives $8.2M grant to test novel male contraceptive pill

The grant will fund a phase 1 placebo-controlled trial in healthy men, including developing an oral formulation, establishing manufacturing protocols and evaluating safety.